ART-002g1

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameART-002g1
Drug Alias NameART002g1ART-002g1
ClassificationOther
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 modulators
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHeterozygous familial hypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Jiao Tong University Affiliated First People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiao Tong University Affiliated First People'S Hospital
Inactive CompaniesN/A
Active IndicationsHeterozygous familial hypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A